NextGen Healthcare Inc. Stock News

NextGen (NXGN) continues to gain momentum on the back of solid demand for its solutions and strength in EHR. Intense competition is a headwind.

Riding high on strategic measures and a solid solvency level, Universal Health (UHS) holds prospects to reap benefits for investors.

Envista (NVST) noted that the Nobel Biocare N1 system represents a significant step further in patient-centric dental implant solutions.

Glaukos Corporation (GKOS) continues to benefit from a robust product portfolio and solid performing iStent technology.

Abbott (ABT) registers strong growth in its more consumer-facing businesses like nutrition, established pharmaceuticals and diabetes care.

DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woes persist.

Strength in Diabetes Care and Diagnostics businesses is driving Abbott's (ABT) top line.

Here are some medical product stocks from the MedTech sector - Quidel (QDEL), Cerus (CERS) and NextGen Healthcare (NXGN) - which might be witnessing a turnaround in 2022 and be solid investment option

NextGen's (NXGN) comprehensive solution suite was adopted by Monmouth to better cater to patients' medical and dental needs.

Related Stocks: NXGN ,

NextGen (NXGN) continues to gain momentum on the back of solid demand for its solutions and strength in EHR.

The average of price targets set by Wall Street analysts indicates a potential upside of 25.4% in Nextgen Healthcare (NXGN). While the effectiveness of this highly sought-after metric is questionable,

This move is a reversal from the day prior, which saw price move up. The post Nextgen Healthcare Inc (NXGN): Price Now Near $16.83; Daily Chart Shows An Uptrend on 50 Day Basis appeared first on ETF Daily News .